- Report
- January 2025
- 175 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- January 2025
- 175 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- January 2025
- 175 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- January 2025
- 175 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- June 2025
- 150 Pages
Global
From €3397EUR$3,850USD£2,938GBP
€4280EUR$4,850USD£3,701GBP
- Report
- June 2025
- 150 Pages
Global
From €3397EUR$3,850USD£2,938GBP
€4280EUR$4,850USD£3,701GBP
- Report
- March 2025
- 150 Pages
Global
From €3397EUR$3,850USD£2,938GBP
€4280EUR$4,850USD£3,701GBP
- Report
- March 2025
- 150 Pages
Global
From €3397EUR$3,850USD£2,938GBP
€4280EUR$4,850USD£3,701GBP
- Report
- November 2024
- 150 Pages
Global
From €3397EUR$3,850USD£2,938GBP
€4280EUR$4,850USD£3,701GBP
- Report
- June 2025
- 183 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- July 2025
Global
From €4324EUR$4,900USD£3,739GBP
- Report
- June 2025
- 100 Pages
Global
From €4324EUR$4,900USD£3,739GBP
From €4324EUR$4,900USD£3,739GBP
From €4324EUR$4,900USD£3,739GBP
From €4324EUR$4,900USD£3,739GBP
- Report
- July 2025
- 175 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- February 2025
- 200 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- August 2025
- 183 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 185 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 196 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share.
The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market.
Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more